ロード中...
Treatment for Lambert‐Eaton myasthenic syndrome
BACKGROUND: Lambert‐Eaton myasthenic syndrome (LEMS) is an autoimmune disorder of neuromuscular transmission. Treatments attempt to overcome the harmful autoimmune process, or improve residual neuromuscular transmission OBJECTIVES: The objective was to examine the efficacy of treatment in Lambert‐Ea...
保存先:
| 出版年: | Cochrane Database Syst Rev |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Ltd
2011
|
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7003613/ https://ncbi.nlm.nih.gov/pubmed/21328260 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD003279.pub3 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|